Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Potential role of adoptively transferred allogeneic WT1-specific CD4+ and CD8+ T lymphocytes for the sustained remission of refractory AML.

× No keyword cloud information.

11 in total

Review 1. Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.

Authors: Premal D Lulla; Maksim Mamonkin; Malcolm K Brenner
Journal: Cancer J Date: 2019 May/Jun Impact factor: 3.360

2. The future of cellular immunotherapy for childhood leukemia.

Authors: Challice L Bonifant; Sarah K Tasian
Journal: Curr Opin Pediatr Date: 2020-02 Impact factor: 2.856

3. Adoptive Immunotherapy after Allogeneic Hematopoietic Progenitor Cell Transplantation: New Perspectives for Transfusion Medicine.

Authors: Susanne Hofmann; Jochen Greiner
Journal: Transfus Med Hemother Date: 2011-05-11 Impact factor: 3.747

4. Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation.

Authors: J-H Yoon; H-J Kim; J-W Kim; Y-W Jeon; S-H Shin; S-E Lee; B-S Cho; K-S Eom; Y-J Kim; S Lee; C-K Min; S-G Cho; J-W Lee; W-S Min; C-W Park
Journal: Bone Marrow Transplant Date: 2014-08-11 Impact factor: 5.483

5. Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells.

Authors: Yong-Rim Kwon; Hye Joung Kim; Min-Jung Sohn; Ji-Young Lim; Kyung-Shin Park; Seok Lee; Nack-Gyun Chung; Dae-Chul Jeong; Chang-Ki Min; Yoo-Jin Kim
Journal: Exp Hematol Oncol Date: 2020-09-03

6. Reactivation of Silenced WT1 Transgene by Hypomethylating Agents - Implications for in vitro Modeling of Chemoimmunotherapy.

Authors: Yong-Rim Kwon; Min-Jung Son; Hye-Jung Kim; Yoo-Jin Kim
Journal: Immune Netw Date: 2012-04-30 Impact factor: 6.303

7. Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.

Authors: Premal D Lulla; Swati Naik; Spyridoula Vasileiou; Ifigeneia Tzannou; Ayumi Watanabe; Manik Kuvalekar; Suhasini Lulla; George Carrum; Carlos A Ramos; Rammurti Kamble; LaQuisa Hill; Jasleen Randhawa; Stephen Gottschalk; Robert Krance; Tao Wang; Mengfen Wu; Catherine Robertson; Adrian P Gee; Betty Chung; Bambi Grilley; Malcolm K Brenner; Helen E Heslop; Juan F Vera; Ann M Leen
Journal: Blood Date: 2021-05-13 Impact factor: 25.476

8. High WT1 expression is an early predictor for relapse in patients with acute promyelocytic leukemia in first remission with negative PML-RARa after anthracycline-based chemotherapy: a single-center cohort study.

Authors: Jae-Ho Yoon; Hee-Je Kim; Dae-Hun Kwak; Sung-Soo Park; Young-Woo Jeon; Sung-Eun Lee; Byung-Sik Cho; Ki-Seong Eom; Yoo-Jin Kim; Seok Lee; Chang-Ki Min; Seok-Goo Cho; Dong-Wook Kim; Jong Wook Lee; Woo-Sung Min
Journal: J Hematol Oncol Date: 2017-01-23 Impact factor: 17.388

9. Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial.

Authors: Hee-Je Kim; Hyun-Jung Sohn; Jung-A Hong; Hyun-Joo Lee; Dae-Hee Sohn; Chang-Ae Shin; Hyun-Il Cho; Woo-Sung Min; Tai-Gyu Kim
Journal: Bone Marrow Transplant Date: 2018-11-08 Impact factor: 5.483

10. [Comparison of the efficacy of decitabine combined with micro-transplantation or priming regimen as consolidation treatment for older patients with acute myeloid leukemia].

Authors: W Y Li; Y F Feng; X Ma; H Y Qiu; C C Fu; X W Tang; Y Han; D P Wu; A N Sun
Journal: Zhonghua Xue Ye Xue Za Zhi Date: 2018-04-14